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We present a case of 7 years history of recurrent febrile syndrome associated with constitutional
symptoms. Extensive investigations failed to identify an etiological agent. Actually, the patient presents
herself with a chest wall tumor and supraclavicular adenopathy.
Computerized tomography (CT) disclosed chest wall abscess, adjacent costal lytic lesions, pulmonary
ﬁbrosis in the left centrohilar area, mediastinal lymphadenopathy, pericardial effusion, partial portal vein
thrombosis, multiple hepatic and splenic hypodense lesions and abdominal lymphadenopathy.
The anatomo-pathological examination of chest wall abscess and supraclavicular adenopathy revealed
epithelioid cell granuloma with caseous necrosis. The evaluation for immunocompromised status has
found no signiﬁcant anomaly.
Antituberculosis chemotherapy resulted in resolution of fever and clinical improvement.
Final diagnosis: disseminated tuberculosis (lymph node, chest wall abscess, pericardial, hepatic,
splenic and pulmonary?) complicated with partial portal vein thrombosis in an immunocompetent host.
 2010 Elsevier Ltd. All rights reserved.1. Introduction
Tuberculosis (TB) can involve any organ system in the body.
While pulmonary TB is the most common presentation, extra-
pulmonary TB is also an important clinical issue. TB remains
a “puzzle disease” due to the diversity of clinical presentation.
Deep venous thrombosis (DVT) may be one of the atypical
presentations of TB, and portal vein thrombosis (PVT) is a rare
manifestation with only two cases reported in the literature.1,2
Prolonged febrile syndrome may be attributed to both of the
ﬂuctuating evolution of disease itself and/or its occult
complications.
2. Case presentation
A 69 year old white woman has been presented with 7 years
history of recurrent febrile syndrome which was associated with
constitutional symptoms (loss of weight, fatigue and malaise).
In the same period she was extensively investigated for a left
centrohilar pseudotumoral process, with serial bronchial and
transthoracic biopsies revealing nonspeciﬁc chronic inﬂammation.
Biological investigations also failed to identify an etiological agent.
Quantiferon-TB Gold test performed 1 year ago was positive, butrved.with no other ﬁndings to support a tuberculous disease, therefore
speciﬁc chemotherapy was not instituted.
She had no signiﬁcant family history. She neither smoked nor
used illicit drugs and had no occupational exposures. There was no
history of travel to tropical areas.
The patient was diagnosed with essential thrombocythemia
(2.000.000/mm3) 3 years ago and had received hydroxyurea for 6
months following which the platelet count normalized.
Actually, the patient presents for the ﬁrst time in our clinic,
having a parietal tumor mass in the right anterior chest wall, that
had increased in size during the last 6 weeks.
She appeared generally emaciated (body mass index ¼ 15.5 kg/
m2), pale and febrile, with fever peaking at 38.5 C. Physical
examination revealed a palpable mass on the right side of sternum,
approximately 7 cm in diameter, with elastic consistency and pain
on pressure, but without hyperemia. Firm right-sided supra-
clavicular adenopathy measuring 1.5 cm in diameter, which was
ﬁxed and non-tender, was also noted.
Splenomegaly (ﬁrm in consistency, smooth surface, and mild
tenderness) was found at abdominal examination, but no evidence
of free ﬂuid in the peritoneal cavity.
A complete blood count revealed that the number of white-cell
was 8500/mm3, with a differential count of 67% granulocytes, 26%
lymphocytes, 4%monocytes, 2% eosinophils, and 1% basophils. The
hemoglobin level was 7.6 g/dl, and the platelet count was
254,000/mm3. The erythrocyte sedimentation rate was 85 mm in
the 1st hour. The serum creatinine level was 0.71 mg/dl, urea
Fig. 2. CT scan of the abdomen e abdominal lymphadenopathy (white arrows),
hepatic hypodense lesions (arrowheads).
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dl. The results of liver-function tests and blood sugar fasting and
postprandial were normal.
Chest CT showed an anterior chest wall abscess and adjacent
costal lytic lesions (anterior costal arch of C1 and C2), without
evidence of underlying lung or pleural disease (Fig. 1). Pulmonary
ﬁbrosis was present in the left centrohilar area. Mediastinal
lymphadenopathies (with a maximal long-axis diameter of 22mm)
and a small pericardial ﬂuid collection were also noted.
Contrast-enhanced CT of the abdomen (Figs. 2 and 3) revealed
splenomegaly measuring 145/180/190 mm, with multiple splenic
hypodense lesions predominantly localized in the upper and lower
pole, with dimensions ranging from 4/4 mm to 32/28 mm. Multiple
hepatic lesions were disclosed, which were hypodense in both
arterial and venous phases, the largest (25 mm), localized in the
third segment.
Celiomesenteric and retroperitoneal lymphadenopathy was
present, appearing as rim-enhancing nodules with central low
attenuation, which created a multilocular appearance (Figs. 2
and 3b).
CT features suggestive for partial portal vein thrombosis were
present, represented by heterogeneous enhancement of the liver
parenchyma, partial opaciﬁcation (lack of contrast substance)
within right portal branch (Fig. 3a) with extension into retro-
pancreatic segment of the portal vein (Fig. 3b), accompanied by
portal-systemic collateral circulation.
The possibility of malignant etiology of hepatosplenic lesions
was considered, but screening examinations (digestive endoscopy,
bronchoscopy, genito-urinary examination) have found no under-
lying malignancy.
The patient underwent surgical resection of both chest wall
abscess and supraclavicular adenopathy. The anatomo-pathological
examination showed granulomas composed of epithelioid histio-
cytes surrounded by lymphocytes. They contained scattered
multinucleated giant cells and had a tendency to conﬂuence. In
some areas, large amounts of caseation necrosis were present in the
center of the coalescent granulomas. These histological features
were consistent with tuberculosis.
Because of anterior invasive procedures (chest wall abscess and
ganglionar resection) the patient refused to undergo laparoscopy/
biopsy at hepatosplenic sites.
The patient was evaluated for immunocompromised status. HIV
was negative and glucose tolerance test was normal. Immuno-
globulin electrophoresis, quantitative immunoglobulin levels,
CD4eCD8 lymphocyte count, complement proteins C3 and C4 and
total complement activity (CH50) were within the normal range.Fig. 1. CT scan of the chest e oval mass in soft tissue density to the right of sternum,
3e7e8 cm in size (white arrow).Immunologic work up including a screening panel for vasculitic
and connective tissue processes were negative.
There was no evidence of opportunistic infections. Staining for
acid-fast bacillus was negative on repetitive sputum specimens.
Antituberculosis chemotherapy was instituted with a daily
regimen of 200 mg isoniazid, 450 mg rifampicin, 1000 mg pyr-
azinamide and 800mg ethambutol, following which fever subsided
and clinical symptoms improved.
The follow-up CT, performed after 3 months of treatment,
showed resolution of the pericardic effusion, marked reduction in
the size of the hepatosplenic lesions and of the abdominal lymph
nodes, and improvement of portal circulation.3. Discussion
The most common etiologies of fever of unknown origin (FUO)
are: infections (30e40%), malignancies (30e40%), collagen vascular
and autoimmune diseases (10e20%); despite exhaustive studies,
a diagnosis is not determined in 5e15% of FUO cases.3 Of the
infectious diseases, TB is the most common cause of FUO, especially
in endemic areas.4
In immunocompetent patients pulmonary TB constitutes
about 75e80% of all cases, extrapulmonary involvement counting
for the rest.5,6
Dissemination, which usually occurs in immunocompromised
patients, represent a challenge in differential diagnosis of FUO,
becausemay initially manifest as constitutional symptoms that lack
localizing signs.
Immunosuppression may be due to the disease itself, or when
an associated condition is present: AIDS, diabetes mellitus,
lymphoma, corticosteroid therapy, therapies with biological agents
(anti-TNF).
The case particularity is a very long lasting period of fever,
without organ involvement. Repeated and extensive investigations
of febrile syndrome (bacteriology, serology) did not identify any
microbial agents. Broad spectrum antibiotic therapy has not inﬂu-
enced the evolution of febrile syndrome.
Although the etiology of left centrohilar pseudotumoral process
remains unclariﬁed, CT features (pulmonary ﬁbrosis) and the context
of extrapulmonary tuberculosis lesions, suggests a posteriori, to be
a very possible tuberculous lesion which was “missed” at bronchial
and transthoracic biopsies as well as at bacteriological exams.
TB is a ﬂuctuating disease with periods of activity/inactivity or
even with spontaneous healing (10e20%). As chronic infectious
disease, it may induce secondary haematological changes.
Fig. 3. a. CT scan of the abdomen e partial right portal branch obstruction (black arrow), splenic hypodense lesion (arrowhead). b. CT scan of the abdomen e partial portal vein
thrombosis within retro-pancreatic segment (black arrow), multiple hepatosplenic hypodense lesions (arrowheads), abdominal lymphadenopathy (white arrows).
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reactive thrombocytosis that appeared 3 years ago.
Several infectious conditions, including TB, can produce
mesenteric lymphadenopathy that mimic lymphoma or metastatic
disease. On CT scans, lymph nodes in these patients, including our,
usually have a multilocular appearance presenting peripheral
enhancement and central caseating areas of necrosis (Fig. 3).
However, this is not a pathognomonic ﬁnding. Usually, inﬂamma-
tory adenopathy does not coalesce, as lymphoma tends to do.
Mesenteric lymph nodes involved by lymphoma usually demon-
strate homogeneous enhancement following intravenous admini-
stration of contrast material.7
Infections can possibly cause venous thrombosis by local inva-
sion of surrounding tissues, compression, direct endothelial
damage, and by producing a transient hypercoagulable state.8,9 TB
is sometimes complicated by DVT and there are isolated reports of
thrombosis occurring in unusual sites, like the portal veins, cerebral
venous sinuses, inferior vena cava. But, portal venous obstruction
or thrombotic portal hypertension is rarely reported.8,9
According to these, in our case, the partial PVT (Fig. 3) might be
due to venous obstruction caused by periportal tuberculous
lymphadenitis, associated with a hypercoagulable state and long
episodes of thrombocythemia, which necessitated treatment with
hydroxyurea for 6 months.
Rarely, PVT may also be a cause of fever, and this associated
condition could have an additive effect to our patient’s febrile
syndrome.
Another particularity of this case is the absence of an associated
immunosuppressing condition. Hydroxyurea has a leucopenic
potential, but is a mildly toxic drug and does not belong in the class
of immunosuppressive drugs.
The QuantiFERON-TB Gold positive test performed 1 year ago
has brought in attention the possibility of a latent or active infection
with bacteria of themycobacterium genus. Although QuantiFERON-
TB Gold test has a speciﬁcity of 98%10 for TB diagnosis, speciﬁc
therapy was temporized due to the absence of organ localisations,
lack of epidemiological factors and of other biological positive data.
Institution of antituberculosis chemotherapy based on patho-
logical conﬁrmation and positive QuantiFERON-TB gold test, has led
to the disappearance of fever with gradual and substantialimprovement of clinical status at 6months (and process is ongoing),
this being another retrospective argument for tuberculosis.
The intermittent febrile pattern, navigation through different
medical sites with nonspeciﬁc features, delayed the diagnosis until,
ﬁnally the patient presented in our clinic, having suggestive local-
izations (chest wall abscessus, supraclavicular adenopathies) ewas
an unfortunately pitfall.
Final diagnosis: disseminated tuberculosis (lymph node, chest
wall abscess, pericardial, hepatic, splenic and pulmonary?)
complicated with partial portal vein thrombosis in an immuno-
competent host.
In summary, a prolonged febrile syndrome may be attributed to
both of the ﬂuctuating evolution of tuberculosis itself and/or its
unusual occult complications.
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